Bayer Competitors and Similar CompaniesClear all
Bayer's competitors and similar companies include Astellas Pharma and AstraZeneca.
 Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ||
Founding Date | Founding Date 1863 | Founding Date 1923 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | |
Employees | Employees 88,5021% decrease | Employees 14,754 | Employees 94,300 |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) 20.8 b | Valuation ($) 2.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) ¥2.1t (FY, 2026) | Revenue (est.) $58.7b (FY, 2025) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods ¥213.8b (FY, 2026) | Cost of goods $4.9b (FY, 2025) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit ¥2t (FY, 2026) | Gross profit $54.2b (FY, 2025) |
Net income | Net income (€3.6b) (FY, 2025) | Net income ¥291.6b (FY, 2026) | Net income $10.2b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries 83 (FY, 2021) | Countries N/A | Countries 130 (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 3.5b | Total funding raised N/A | Total funding raised $ 1b |
For sources of this data, please see the company profile
View Company Profiles
Astellas Pharma
HQ
Tokyo, JP
Employees
14,754
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company